Skip to main content

Table 1 Baseline characteristics of patients included in the study at the time of enrollment in the study

From: A randomized trial to monitor the efficacy and effectiveness by QT-NASBA of artemether-lumefantrine versus dihydroartemisinin-piperaquine for treatment and transmission control of uncomplicated Plasmodium falciparum malaria in western Kenya

Characteristic

DHA-PQP (n = 73)

ALN (n = 73)

Sex ratio male:female

33:40

40:33

Age (in months), median (IQR)

60 (44)

52 (44)

Body weight, mean kg (range)

17.62 (6–37)

17.32 (6–42)

Temperature, mean °C ± SD

38.1 ± 0.99

37.8 ± 0.73

Haemoglobin mmol/L ± SD

6.33 ± 1.29

6.28 ± 1.27

Parasites/μl geometric mean (range) as determined by microscopy

12145 (1000–72640)

13379 (1080–72000)